Clinical Trials On Demand Webinar

Please join Andrew Blauvelt, M.D, MBA, for this Clinical Trials webinar designed to engage health care professionals in the process of increasing the number of patients in psoriatic disease clinical trials, building long-term benefits that will advance patient-centered outcomes through research, and improve the lives of those impacted by psoriatic disease.
 

This program is supported by unrestricted educational grants from Eli Lilly & Company, Celgene Corporation, Valeant Pharmaceuticals North America, LLC and Dermira Inc..

IF YOU DO NOT YET HAVE AN ACCOUNT WITH THE NATIONAL PSORIASIS FOUNDATION, PLEASE CLICK HERE TO CREATE A NEW ACCOUNT PRIOR TO TAKING THIS COURSE. THANK YOU! 

Accreditation Statement

The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit

The National Psoriasis Foundation designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity

Target Audience

Dermatologists, Rheumatologists, primary care physicians, and allied health providers

Learning Objectives

  1. Identify resources and best practices for recruiting and communicating with participants
  1. Identify and respond to common questions and concerns patients may have about participating in a clinical trial to ensure informed consent is a shared decision making process
  1. Utilize best practices in preparing for and implementing a psoriatic disease clinical trial in their practice
  1. Identify resources and information necessary to keep abreast of relevant clinical trials and confidently screen and recommend potential patients for participation.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Accreditation

    This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint providership of Oregon Health & Science University (OHSU) and the National Psoriasis Foundation. OHSU is accredited by the ACCME to provide CME for physicians.

    Credit

    OHSU School of Medicine, Division of CME, designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 CE
Course opens: 
10/05/2017
Course expires: 
10/05/2019
Cost:
$0.00
Rating: 
0

Andrew Blauvelt, MD, MBA

President and Investigator

Oregon Medical Research Center

Portland, Oregon

Disclosure link

Accreditation Period

Course opens: 
10/05/2017
Course expires: 
10/05/2019

Price

Cost:
$0.00
Please login to take this course.